Atlas Trials

ALK33BUP-101: Safety and Pharmacodynamic Effects of ALKS 33-BUP Administered Alone and When Co-administered With Cocaine

Clinical trial NCT01366001 · COMPLETED

Trial details

NCT number
NCT01366001
Sponsor
Alkermes, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cocaine Abuse
Start date
2011-08-01
Primary completion
2012-02-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.